Cargando…

Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study

BACKGROUND: Lung resection and one lung ventilation (OLV) during video-assisted thoracoscopic surgery (VATS) may lead to acute lung injury. Dexmedetomidine (DEX), a highly selective α(2) adrenergic receptor agonist, improves arterial oxygenation in adult patients undergoing thoracic surgery. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linjia, Zhang, Yang, Zhang, Zhenfeng, Ding, Xiahao, Gong, Chanjuan, Qian, Yanning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699453/
https://www.ncbi.nlm.nih.gov/pubmed/33262576
http://dx.doi.org/10.2147/DDDT.S276005
_version_ 1783616052315291648
author Zhu, Linjia
Zhang, Yang
Zhang, Zhenfeng
Ding, Xiahao
Gong, Chanjuan
Qian, Yanning
author_facet Zhu, Linjia
Zhang, Yang
Zhang, Zhenfeng
Ding, Xiahao
Gong, Chanjuan
Qian, Yanning
author_sort Zhu, Linjia
collection PubMed
description BACKGROUND: Lung resection and one lung ventilation (OLV) during video-assisted thoracoscopic surgery (VATS) may lead to acute lung injury. Dexmedetomidine (DEX), a highly selective α(2) adrenergic receptor agonist, improves arterial oxygenation in adult patients undergoing thoracic surgery. The aim of this pilot study was to explore possible mechanism related to lung protection of DEX in patients undergoing VATS. PATIENTS AND METHODS: Seventy-four patients scheduled for VATS were enrolled in this study. Three timepoints (before anesthesia induction (T(0)), 40 min after OLV (T(1)), and 10 min after two-lung ventilation (T(2))) of arterial blood gas were obtained. Meanwhile, lung histopathologic examination, immunohistochemistry analysis (occludin and ZO-1), levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 in lung tissue and plasma, and activation of phosphoinositide-3-kinase (PI3K)/AKT/hypoxia-inducible factor (HIF)-1α signaling were detected. Postoperative outcomes including duration of withdrawing the pleural drainage tube, length of hospital stay, hospitalization expenses, and postoperative pulmonary complications (PPCs) were also recorded. RESULTS: Sixty-seven patients were randomly divided into DEX group (group D, n=33) and control group (group N, n=34). DEX improved oxygenation at T(1) and T(2) (group D vs group N; T(1): 191.8 ± 49.8 mmHg vs 159.6 ± 48.1 mmHg, P = 0.009; T(2): 406.0 mmHg [392.2–423.7] vs 374.5 mmHg [340.2–378.2], P = 0.001). DEX alleviated the alveolar capillary epithelial structure damage, increased protein expression of ZO-1 and occludin, inhibited elevation of the expression of TNF-α and IL-6 in lung tissue and plasma, and increased protein expression of p-PI3K, p-AKT and HIF-1α. Dex administered had better postoperative outcomes with less risk of PPCs and hospitalization expenses as well as shorter duration of withdrawing the pleural drainage tube and length of hospital stay. CONCLUSION: Activation of PI3K/Akt/HIF-1α signaling might be involved in lung protection of DEX in patients undergoing VATS.
format Online
Article
Text
id pubmed-7699453
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76994532020-11-30 Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study Zhu, Linjia Zhang, Yang Zhang, Zhenfeng Ding, Xiahao Gong, Chanjuan Qian, Yanning Drug Des Devel Ther Original Research BACKGROUND: Lung resection and one lung ventilation (OLV) during video-assisted thoracoscopic surgery (VATS) may lead to acute lung injury. Dexmedetomidine (DEX), a highly selective α(2) adrenergic receptor agonist, improves arterial oxygenation in adult patients undergoing thoracic surgery. The aim of this pilot study was to explore possible mechanism related to lung protection of DEX in patients undergoing VATS. PATIENTS AND METHODS: Seventy-four patients scheduled for VATS were enrolled in this study. Three timepoints (before anesthesia induction (T(0)), 40 min after OLV (T(1)), and 10 min after two-lung ventilation (T(2))) of arterial blood gas were obtained. Meanwhile, lung histopathologic examination, immunohistochemistry analysis (occludin and ZO-1), levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 in lung tissue and plasma, and activation of phosphoinositide-3-kinase (PI3K)/AKT/hypoxia-inducible factor (HIF)-1α signaling were detected. Postoperative outcomes including duration of withdrawing the pleural drainage tube, length of hospital stay, hospitalization expenses, and postoperative pulmonary complications (PPCs) were also recorded. RESULTS: Sixty-seven patients were randomly divided into DEX group (group D, n=33) and control group (group N, n=34). DEX improved oxygenation at T(1) and T(2) (group D vs group N; T(1): 191.8 ± 49.8 mmHg vs 159.6 ± 48.1 mmHg, P = 0.009; T(2): 406.0 mmHg [392.2–423.7] vs 374.5 mmHg [340.2–378.2], P = 0.001). DEX alleviated the alveolar capillary epithelial structure damage, increased protein expression of ZO-1 and occludin, inhibited elevation of the expression of TNF-α and IL-6 in lung tissue and plasma, and increased protein expression of p-PI3K, p-AKT and HIF-1α. Dex administered had better postoperative outcomes with less risk of PPCs and hospitalization expenses as well as shorter duration of withdrawing the pleural drainage tube and length of hospital stay. CONCLUSION: Activation of PI3K/Akt/HIF-1α signaling might be involved in lung protection of DEX in patients undergoing VATS. Dove 2020-11-24 /pmc/articles/PMC7699453/ /pubmed/33262576 http://dx.doi.org/10.2147/DDDT.S276005 Text en © 2020 Zhu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhu, Linjia
Zhang, Yang
Zhang, Zhenfeng
Ding, Xiahao
Gong, Chanjuan
Qian, Yanning
Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study
title Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study
title_full Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study
title_fullStr Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study
title_full_unstemmed Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study
title_short Activation of PI3K/Akt/HIF-1α Signaling is Involved in Lung Protection of Dexmedetomidine in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Pilot Study
title_sort activation of pi3k/akt/hif-1α signaling is involved in lung protection of dexmedetomidine in patients undergoing video-assisted thoracoscopic surgery: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699453/
https://www.ncbi.nlm.nih.gov/pubmed/33262576
http://dx.doi.org/10.2147/DDDT.S276005
work_keys_str_mv AT zhulinjia activationofpi3kakthif1asignalingisinvolvedinlungprotectionofdexmedetomidineinpatientsundergoingvideoassistedthoracoscopicsurgeryapilotstudy
AT zhangyang activationofpi3kakthif1asignalingisinvolvedinlungprotectionofdexmedetomidineinpatientsundergoingvideoassistedthoracoscopicsurgeryapilotstudy
AT zhangzhenfeng activationofpi3kakthif1asignalingisinvolvedinlungprotectionofdexmedetomidineinpatientsundergoingvideoassistedthoracoscopicsurgeryapilotstudy
AT dingxiahao activationofpi3kakthif1asignalingisinvolvedinlungprotectionofdexmedetomidineinpatientsundergoingvideoassistedthoracoscopicsurgeryapilotstudy
AT gongchanjuan activationofpi3kakthif1asignalingisinvolvedinlungprotectionofdexmedetomidineinpatientsundergoingvideoassistedthoracoscopicsurgeryapilotstudy
AT qianyanning activationofpi3kakthif1asignalingisinvolvedinlungprotectionofdexmedetomidineinpatientsundergoingvideoassistedthoracoscopicsurgeryapilotstudy